Pharmacokinetic study of minocycline in patients with nontuberculous mycobacterial disease

2024-517758-87-00 Protocol Mino-PK Human pharmacology (Phase I) - Bioequivalence study Ended

Start 22 Jun 2023 · End 11 Jun 2025 · Status Ended · 1 EU/EEA countries · 1 sites · Protocol Mino-PK

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Bioequivalence study
Status Ended
Participants planned 15
Countries 1
Sites 1

Nontuberculous mycobacterial disease

Key facts

Sponsor
Radboud universitair medisch centrum Stichting
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutics [E02], Diseases [C] - Bacterial Infections and Mycoses [C01]
Trial duration
22 Jun 2023 → 11 Jun 2025
Decision date (initial)
2024-09-24
Transition trial
Yes
Low-intervention
No
Rare-disease indication
Yes
Vulnerable population
No

External identifiers

EU CT number
2024-517758-87-00
EudraCT number
2019-000938-20
ClinicalTrials.gov
NCT05861258

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Nontuberculous mycobacterial disease

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Radboud universitair medisch centrum Stichting

Sponsor organisation
Radboud universitair medisch centrum Stichting
Address
Geert Grooteplein Zuid 10
City
Nijmegen
Postcode
6525 GA
Country
Netherlands

Scientific contact point

Organisation
Radboud universitair medisch centrum Stichting
Contact name
Arthur Lemson

Public contact point

Organisation
Radboud universitair medisch centrum Stichting
Contact name
Arthur Lemson

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Netherlands Ended 15 1
Rest of world 0

Investigational sites

Netherlands

1 site · Ended
Radboud universitair medisch centrum Stichting
Pulmonary Diseased, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Netherlands 2023-06-22 2023-06-23 2025-05-09

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-09-06 Netherlands Acceptable with conditions
2024-09-24
2024-09-24